Novel and Traditional Cardiovascular Risk Factors for Peripheral Arterial Disease in Incident-Dialysis Patients
Peripheral arterial disease (PAD), which threatens limb viability and patient survival, is increasing in frequency in the dialysis population, but associated risk factors remain poorly defined. We conducted a cross-sectional analysis of the association of novel and traditional cardiovascular risk factors with PAD in incident-dialysis patients enrolled in the CHOICE study by application of multivariate logistic-regression models with adjustment for confounders. Risk factors were determined by interview, record review, and laboratory analysis of frozen specimens. Among 922 patients, 25% had a diagnosis of PAD. After adjustment, higher prevalence of PAD was associated with increasing age (odds ratio [OR], 95% CI = 1.28 [range: 1.12 to 1.48] per 10-year increase in age); presence of diabetes mellitus (OR, 95% CI = 2.76 [range: 1.72 to 4.42]); higher Index of Co-Existent Disease (ICED), ICED 2 and ICED 3 versus ICED 0-1, (OR, 95% CI = 2.04; [range: 1.24 to 3.35] and OR, 95% CI = 2.81 [range: 1.83 to 4.30], respectively). After adjustment, we found no statistically significant association between CRP and prevalence of PAD. The prevalence of PAD diagnosis was 34% higher per quartile increase in Lp(a) (OR, 95% CI = 1.34 [range: 1.13 to 1.59]). Similarly, the prevalence of PAD diagnosis was 19% higher per quartile increase in total homocysteine (OR, 95% CI = 1.19 [range: 1.05 to 1.35]). The prevalence of PAD is high in incident-dialysis patients and is associated with several novel and traditional cardiovascular risk factors. This study identifies several novel risk factors (eg, Lp(a) and total homocysteine) and underscores the need for further research to reduce the burden of PAD in this high-risk group of patients.
dDepartment of Community Medicine, Kuwait University, Safat, Kuwait
eLaboratory for Clinical Biochemistry Research, Department of Pathology, University of Vermont, Colchester, VT
fNorthwest Lipid Research Laboratories, University of Washington, Seattle, WA
gDepartment of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD
hDepartment of Biostatistics, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.
Address correspondence to Bernard G. Jaar, MD, MPH, Johns Hopkins Medical Institutions, Division of Nephrology, 2024 E. Monument Street, Suite 2-500, Baltimore, MD 21205.
CHOICE is supported by RO1-HL-62985 (National Heart, Lung, and Blood Institute [NHLBI]) and RO1-DK-59616 (National Institute of Diabetes & Digestive & Kidney Diseases [NIDDK]).
1 Dr. Coresh is supported in part as an American Heart Association established investigator (01-4019-7N).
2 Dr Tracy is supported in part by HL 46696 and HL 58329.
3 Dr. Powe is supported in part by K24-DK-02643 (NIDDK).